Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
25.16
-0.58 (-2.25%)
At close: Feb 21, 2025, 4:00 PM
25.30
+0.14 (0.56%)
After-hours: Feb 21, 2025, 7:46 PM EST
Pacira BioSciences Market Cap
Pacira BioSciences has a market cap or net worth of $1.16 billion as of February 21, 2025. Its market cap has decreased by -19.67% in one year.
Market Cap
1.16B
Enterprise Value
1.35B
1-Year Change
-19.67%
Ranking
Category
Stock Price
$25.16
Market Cap Chart
Since February 3, 2011, Pacira BioSciences's market cap has increased from $121.00M to $1.16B, an increase of 860.10%. That is a compound annual growth rate of 17.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 1.19B | 36.62% |
| Dec 31, 2024 | 869.90M | -44.48% |
| Dec 29, 2023 | 1.57B | -11.56% |
| Dec 30, 2022 | 1.77B | -33.90% |
| Dec 31, 2021 | 2.68B | 3.10% |
| Dec 31, 2020 | 2.60B | 37.52% |
| Dec 31, 2019 | 1.89B | 6.88% |
| Dec 31, 2018 | 1.77B | -4.50% |
| Dec 29, 2017 | 1.85B | 53.30% |
| Dec 30, 2016 | 1.21B | -57.20% |
| Dec 31, 2015 | 2.82B | -11.70% |
| Dec 31, 2014 | 3.20B | 65.79% |
| Dec 31, 2013 | 1.93B | 239.05% |
| Dec 31, 2012 | 568.70M | 281.68% |
| Dec 30, 2011 | 149.00M | 23.14% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 788.96B |
| UnitedHealth Group | 430.27B |
| Johnson & Johnson | 391.62B |
| Novo Nordisk | 370.84B |
| AbbVie | 358.46B |
| Abbott Laboratories | 233.67B |
| AstraZeneca | 229.50B |
| Merck & Co. | 224.91B |